Histopathological evaluation of caffeine-loaded solid lipid nanoparticles in efficient treatment of cellulite

References

• Piérard GE, Nizet J-L, Piérard-Franchimont C. Cellulite: from standing fat herniation to hypodermal stretch marks. Am J Dermatopathol 2000;22:34–7
   PubMed Web of Science ®Google Scholar
• Rosenbaum M, Prieto V, Hellmer J, et al. An exploratory investigation of the morphology and biochemistry of cellulite. Plast Reconstr Surg 1998;101:1934–9
   PubMed Web of Science ®Google Scholar
• Lotti T, Ghersetich I, Grappone C, et al. Proteoglycans in so-called cellulite. Int J Dermatol 1990;29:272–4
   PubMed Web of Science ®Google Scholar
• Rossi ABR, Vergnanini AL. Cellulite: a review. J Eur Acad Dermatol Venereol 2000;14:251–62
   PubMed Web of Science ®Google Scholar
• Avram MM. Cellulite: a review of its physiology and treatment. J Cosmet Laser Ther 2004;6:181–5
   PubMedGoogle Scholar
• Nürnberger F, Müller G. So-called cellulite: an invented disease. J Dermatol Surg Onc 1978;4:221–9
   PubMedGoogle Scholar
• Roure R, Oddos T, Rossi A, et al. Evaluation of the efficacy of a topical cosmetic slimming product combining tetrahydroxypropyl ethylenediamine, caffeine, carnitine, forskolin and retinol, In vitro, ex vivo and in vivo studies. Int J Cosmetic Sci 2011;33:519–26
   PubMed Web of Science ®Google Scholar
• Khan MH, Victor F, Rao B, et al. Treatment of cellulite: Part II. Advances and controversies. J Am Acad Dermatol 2010;62:373–84
   PubMed Web of Science ®Google Scholar
• Al-Bader T, Byrne A, Gillbro J, et al. Effect of cosmetic ingredients as anticellulite agents: synergistic action of actives with in vitro and in vivo efficacy. J Cosmet Dermatol 2012;11:17–26
   PubMed Web of Science ®Google Scholar
• Lesser T, Ritvo E, Moy LS. Modification of subcutaneous adipose tissue by a methylxanthine formulation: a double-blind controlled study. Dermatol Surg 1999;25:455–62
   PubMed Web of Science ®Google Scholar
• Bertin C, Zunino H, Pittet J-C, et al. A double-blind evaluation of the activity of an anti-cellulite product containing retinol, caffeine, and ruscogenine by a combination of several non-invasive methods. J Cosmet Sci 2001;52:199–210
   PubMed Web of Science ®Google Scholar
• Bolzinger M-A, Briançon S, Pelletier J, et al. Percutaneous release of caffeine from microemulsion, emulsion and gel dosage forms. Eur J Pharm Biopharm 2008;68:446–51
   PubMed Web of Science ®Google Scholar
• Kim C, Shim J, Han S, et al. The skin-permeation-enhancing effect of phosphatidylcholine: caffeine as a model active ingredient. J Cosmet Sci 2002;53:363–74
   PubMed Web of Science ®Google Scholar
• Rubio L, Alonso C, López O, et al. Barrier function of intact and impaired skin: percutaneous penetration of caffeine and salicylic acid. Int J Dermatol 2011;50:881–9
   PubMed Web of Science ®Google Scholar
• Elias P, Feingold K. Stratum corneum barrier function: definitions and broad concepts. In: Elias P, Feingold K, eds. Skin barrier. New York (NY): Taylor & Francis; 2006:1–4
   Google Scholar
• Hexsel D, Orlandi C, Zechmeister do Prado D. Botanical extracts used in the treatment of cellulite. Dermatol Surg 2005;31:866–73
   PubMed Web of Science ®Google Scholar
• Harding CR. The stratum corneum: structure and function in health and disease. Dermatol Ther 2004;17:6–15
   PubMedGoogle Scholar
• Mei Z, Chen H, Weng T, et al. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm 2003;56:189–96
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009;366:170–84
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Del Rev 2001;47:165–96
   PubMed Web of Science ®Google Scholar
• Wissing SA, Müller RH. Cosmetic applications for solid lipid nanoparticles (SLN). Int J Pharm 2003;254:65–8
   PubMed Web of Science ®Google Scholar
• Lopes LB, Ferreira DA, de Paula D, et al. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A. Pharm Res 2006;23:1332–42
   PubMed Web of Science ®Google Scholar
• Liu J, Hu W, Chen H, et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm 2007;328:191–5
   PubMed Web of Science ®Google Scholar
• Munster U, Nakamura C, Haberland A, et al. RU 58841-myristate prodrug development for topical treatment of acne and androgenetic alopecia. Die Pharmazie 2005;60:8–12
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 2000;50:161–77
   PubMed Web of Science ®Google Scholar
• Iannuccelli V, Sala N, Tursilli R, et al. Influence of liposphere preparation on butyl-methoxydibenzoylmethane photostability. Eur J Pharm Biopharm 2006;63:140–5
   PubMed Web of Science ®Google Scholar
• Shah KA, Date AA, Joshi MD, et al. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm 2007;345:163–71
   PubMed Web of Science ®Google Scholar
• Müller R, Radtke M, Wissing S. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Del Rev 2002;54:S131–55
   PubMed Web of Science ®Google Scholar
• Müller RH, Lucks J. Inventors; Arzneistofftrager aus festen lipid-teilchen, feste lipidnanospharen (SLN), patent EP0605497A1, 1996
   Google Scholar
• Gasco MR. Method for producing solid lipid microspheres having a narrow size distribution. Google Patents; 1993
   Google Scholar
• Chen H, Chang X, Du D, et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Controlled Release 2006;110:296–306
   PubMed Web of Science ®Google Scholar
• Mezzena M, Scalia S, Young P, et al. Solid lipid budesonide microparticles for controlled release inhalation therapy. AAPS J 2009;11:771–8
   PubMed Web of Science ®Google Scholar
• Elias PM. Stratum corneum defensive functions: an integrated view. J Gen Intern Med 2005;20:183–200
   Google Scholar
• Sinico C, Fadda A. Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv 2009;6:813–25
   PubMed Web of Science ®Google Scholar
• Mihranyan A, Ferraz N, Strømme M. Current status and future prospects of nanotechnology in cosmetics. Prog Mater Sci 2012;57:875–910
   Web of Science ®Google Scholar
• Rossi AM, Katz BE. A modern approach to the treatment of cellulite. Dermatol Clin 2014;32:51–9
   PubMed Web of Science ®Google Scholar